admin, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

Lykos Plots FDA Appeal: Reeling from CRL and Journal Article Retractions,...

Why Psychedelic Practitioners Should be Trauma-Informed

BREAKING: FDA Rejects Lykos Therapeutics’ MDMA-Assisted Therapy For PTSD

Microdosing at Work: How Psychedelics are Creating Better Leaders

Somatic Therapy and Psychedelics: How Body-Centered Approaches Are Revolutionizing Trauma Treatment

Psychedelics Today Live Podcast

The Enneagram: A Dynamic Framework for Self-Discovery

Psychedelics and Creativity, Endo-Tripping, and the Origins of Life on Earth

Vibe Check: FDA Set to Decide Future of MDMA-Assisted Therapy This...

Pioneering Psychedelic Policy: Nevada’s Senate Bill 242 and Beyond

1...121314...218 Page 13 of 218

EDITOR PICKS

From Huxley to Heffter: Mark Geyer Reflects on a Life in...

Advanced Shadow Work and Psychedelic Integration: A Jungian Path to Wholeness

Essentials of Psychedelic Therapy & Integration

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin